Molecular imaging of neutropilin-1 receptor using photoacoustic spectroscopy in breast tumors

Keith M. Stantz, Minsong Cao, Bo Liu, Kathy Miller, Lili Guo

Research output: Chapter in Book/Report/Conference proceedingConference contribution

7 Citations (Scopus)

Abstract

Purpose: Our purpose is to develop and test a molecular probe that can detect the expression of neutropilin-1 receptor (NPR-1) in vivo using fluorescence imaging and photoacoustic spectroscopy. Introduction: NPR-1 is expressed on endothelial cells and some breast cancer cells, and binds to vascular endothelial growth factor VEGF165, a growth factor associated with pathological tumor angiogenesis. This receptor is coexpressed with VEGFR2 and shown to enhance the binding of VEGF165; therefore, it has the potential to be used as a marker of angiogenic activity and targeted for therapy. Material and Methods: A peptide specific to NPR-1 receptor was synthesized and conjugated to a NIR fluorochrome (IRDye800CW) and was intravenously injected into mice with breast tumors (MCF7VEGF). Probe kinetics was monitored in vivo via near infrared fluorescence (NIRF) within an optical imager for up to 72 hours within the tumor and compared to other organs (liver, muscle) for binding specificity. A multivariate fitting algorithm was used to spectrally deconvolve the IRDye800CW from endogenous hemoglobin signature (hemoglobin concentration and oxygen saturation). Results: Dynamics of the NIR fluorescence signal within the first hour after injection indicates specific binding compared to muscle, with an average tumor-to-muscle ration of 2.00 (+/- 0.27). Spectral analysis clearly indentified the presence of the NPR-1 probe. Based on calibration data, the average tumor concentration from both NIRF and PCT-S was measured to be ∼200-300nM. Conclusion: These preliminary results show the capability of PCT to image an exogenous probe in vivo in addition to its hemoglobin state.

Original languageEnglish
Title of host publicationProgress in Biomedical Optics and Imaging - Proceedings of SPIE
Volume7564
DOIs
StatePublished - 2010
EventPhotons Plus Ultrasound: Imaging and Sensing 2010 - San Francisco, CA, United States
Duration: Jan 24 2010Jan 26 2010

Other

OtherPhotons Plus Ultrasound: Imaging and Sensing 2010
CountryUnited States
CitySan Francisco, CA
Period1/24/101/26/10

Fingerprint

Photoacoustic spectroscopy
Molecular imaging
photoacoustic spectroscopy
Molecular Imaging
breast
Tumors
Spectrum Analysis
tumors
Breast Neoplasms
Hemoglobin
hemoglobin
muscles
Hemoglobins
Fluorescence
Muscle
fluorescence
Muscles
probes
Neoplasms
Pathologic Neovascularization

Keywords

  • Angiogenesis
  • Breast cancer
  • Neutropilin-1 receptor
  • Photoacoustic computed tomographic spectroscopy

ASJC Scopus subject areas

  • Atomic and Molecular Physics, and Optics
  • Electronic, Optical and Magnetic Materials
  • Biomaterials
  • Radiology Nuclear Medicine and imaging

Cite this

Stantz, K. M., Cao, M., Liu, B., Miller, K., & Guo, L. (2010). Molecular imaging of neutropilin-1 receptor using photoacoustic spectroscopy in breast tumors. In Progress in Biomedical Optics and Imaging - Proceedings of SPIE (Vol. 7564). [75641O] https://doi.org/10.1117/12.842271

Molecular imaging of neutropilin-1 receptor using photoacoustic spectroscopy in breast tumors. / Stantz, Keith M.; Cao, Minsong; Liu, Bo; Miller, Kathy; Guo, Lili.

Progress in Biomedical Optics and Imaging - Proceedings of SPIE. Vol. 7564 2010. 75641O.

Research output: Chapter in Book/Report/Conference proceedingConference contribution

Stantz, KM, Cao, M, Liu, B, Miller, K & Guo, L 2010, Molecular imaging of neutropilin-1 receptor using photoacoustic spectroscopy in breast tumors. in Progress in Biomedical Optics and Imaging - Proceedings of SPIE. vol. 7564, 75641O, Photons Plus Ultrasound: Imaging and Sensing 2010, San Francisco, CA, United States, 1/24/10. https://doi.org/10.1117/12.842271
Stantz KM, Cao M, Liu B, Miller K, Guo L. Molecular imaging of neutropilin-1 receptor using photoacoustic spectroscopy in breast tumors. In Progress in Biomedical Optics and Imaging - Proceedings of SPIE. Vol. 7564. 2010. 75641O https://doi.org/10.1117/12.842271
Stantz, Keith M. ; Cao, Minsong ; Liu, Bo ; Miller, Kathy ; Guo, Lili. / Molecular imaging of neutropilin-1 receptor using photoacoustic spectroscopy in breast tumors. Progress in Biomedical Optics and Imaging - Proceedings of SPIE. Vol. 7564 2010.
@inproceedings{4f22101c19a54dabae633cf5e3c7aef5,
title = "Molecular imaging of neutropilin-1 receptor using photoacoustic spectroscopy in breast tumors",
abstract = "Purpose: Our purpose is to develop and test a molecular probe that can detect the expression of neutropilin-1 receptor (NPR-1) in vivo using fluorescence imaging and photoacoustic spectroscopy. Introduction: NPR-1 is expressed on endothelial cells and some breast cancer cells, and binds to vascular endothelial growth factor VEGF165, a growth factor associated with pathological tumor angiogenesis. This receptor is coexpressed with VEGFR2 and shown to enhance the binding of VEGF165; therefore, it has the potential to be used as a marker of angiogenic activity and targeted for therapy. Material and Methods: A peptide specific to NPR-1 receptor was synthesized and conjugated to a NIR fluorochrome (IRDye800CW) and was intravenously injected into mice with breast tumors (MCF7VEGF). Probe kinetics was monitored in vivo via near infrared fluorescence (NIRF) within an optical imager for up to 72 hours within the tumor and compared to other organs (liver, muscle) for binding specificity. A multivariate fitting algorithm was used to spectrally deconvolve the IRDye800CW from endogenous hemoglobin signature (hemoglobin concentration and oxygen saturation). Results: Dynamics of the NIR fluorescence signal within the first hour after injection indicates specific binding compared to muscle, with an average tumor-to-muscle ration of 2.00 (+/- 0.27). Spectral analysis clearly indentified the presence of the NPR-1 probe. Based on calibration data, the average tumor concentration from both NIRF and PCT-S was measured to be ∼200-300nM. Conclusion: These preliminary results show the capability of PCT to image an exogenous probe in vivo in addition to its hemoglobin state.",
keywords = "Angiogenesis, Breast cancer, Neutropilin-1 receptor, Photoacoustic computed tomographic spectroscopy",
author = "Stantz, {Keith M.} and Minsong Cao and Bo Liu and Kathy Miller and Lili Guo",
year = "2010",
doi = "10.1117/12.842271",
language = "English",
isbn = "9780819479600",
volume = "7564",
booktitle = "Progress in Biomedical Optics and Imaging - Proceedings of SPIE",

}

TY - GEN

T1 - Molecular imaging of neutropilin-1 receptor using photoacoustic spectroscopy in breast tumors

AU - Stantz, Keith M.

AU - Cao, Minsong

AU - Liu, Bo

AU - Miller, Kathy

AU - Guo, Lili

PY - 2010

Y1 - 2010

N2 - Purpose: Our purpose is to develop and test a molecular probe that can detect the expression of neutropilin-1 receptor (NPR-1) in vivo using fluorescence imaging and photoacoustic spectroscopy. Introduction: NPR-1 is expressed on endothelial cells and some breast cancer cells, and binds to vascular endothelial growth factor VEGF165, a growth factor associated with pathological tumor angiogenesis. This receptor is coexpressed with VEGFR2 and shown to enhance the binding of VEGF165; therefore, it has the potential to be used as a marker of angiogenic activity and targeted for therapy. Material and Methods: A peptide specific to NPR-1 receptor was synthesized and conjugated to a NIR fluorochrome (IRDye800CW) and was intravenously injected into mice with breast tumors (MCF7VEGF). Probe kinetics was monitored in vivo via near infrared fluorescence (NIRF) within an optical imager for up to 72 hours within the tumor and compared to other organs (liver, muscle) for binding specificity. A multivariate fitting algorithm was used to spectrally deconvolve the IRDye800CW from endogenous hemoglobin signature (hemoglobin concentration and oxygen saturation). Results: Dynamics of the NIR fluorescence signal within the first hour after injection indicates specific binding compared to muscle, with an average tumor-to-muscle ration of 2.00 (+/- 0.27). Spectral analysis clearly indentified the presence of the NPR-1 probe. Based on calibration data, the average tumor concentration from both NIRF and PCT-S was measured to be ∼200-300nM. Conclusion: These preliminary results show the capability of PCT to image an exogenous probe in vivo in addition to its hemoglobin state.

AB - Purpose: Our purpose is to develop and test a molecular probe that can detect the expression of neutropilin-1 receptor (NPR-1) in vivo using fluorescence imaging and photoacoustic spectroscopy. Introduction: NPR-1 is expressed on endothelial cells and some breast cancer cells, and binds to vascular endothelial growth factor VEGF165, a growth factor associated with pathological tumor angiogenesis. This receptor is coexpressed with VEGFR2 and shown to enhance the binding of VEGF165; therefore, it has the potential to be used as a marker of angiogenic activity and targeted for therapy. Material and Methods: A peptide specific to NPR-1 receptor was synthesized and conjugated to a NIR fluorochrome (IRDye800CW) and was intravenously injected into mice with breast tumors (MCF7VEGF). Probe kinetics was monitored in vivo via near infrared fluorescence (NIRF) within an optical imager for up to 72 hours within the tumor and compared to other organs (liver, muscle) for binding specificity. A multivariate fitting algorithm was used to spectrally deconvolve the IRDye800CW from endogenous hemoglobin signature (hemoglobin concentration and oxygen saturation). Results: Dynamics of the NIR fluorescence signal within the first hour after injection indicates specific binding compared to muscle, with an average tumor-to-muscle ration of 2.00 (+/- 0.27). Spectral analysis clearly indentified the presence of the NPR-1 probe. Based on calibration data, the average tumor concentration from both NIRF and PCT-S was measured to be ∼200-300nM. Conclusion: These preliminary results show the capability of PCT to image an exogenous probe in vivo in addition to its hemoglobin state.

KW - Angiogenesis

KW - Breast cancer

KW - Neutropilin-1 receptor

KW - Photoacoustic computed tomographic spectroscopy

UR - http://www.scopus.com/inward/record.url?scp=77951601970&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77951601970&partnerID=8YFLogxK

U2 - 10.1117/12.842271

DO - 10.1117/12.842271

M3 - Conference contribution

SN - 9780819479600

VL - 7564

BT - Progress in Biomedical Optics and Imaging - Proceedings of SPIE

ER -